Target intelligence / Profile preview

UFM1 specific peptidase 1 (UFSP1)

Target
UFSP1
Molecular classification
Enzyme, Cysteine protease, Ubiquitin-like protein-processing enzyme
01

Overview

UFM1 specific peptidase 1 (UFSP1) is an **active cysteine protease enzyme** involved in the post-translational modification pathway known as UFMylation, which is a ubiquitin-like system unique to metazoans and plants. UFSP1 is responsible for the **maturation of UFM1** (ubiquitin-fold modifier 1) by cleaving its C-terminal Ser-Cys dipeptide to expose the critical glycine residue required for subsequent conjugation to substrate proteins. Additionally, UFSP1, alongside UFSP2, catalyzes the removal of UFM1 from protein substrates, a process termed **de-UFMylation**. UFSP1 is widely expressed (though at a lower level than UFSP2 in humans), localizes primarily in the cytosol, and initiates translation from an upstream CUG codon, not the canonical AUG, to produce the active protease form[1][3]. The UFMylation pathway is **implicated in cellular processes such as erythropoiesis, endoplasmic reticulum (ER) homeostasis, and response to stress**, and deficiencies or mutations in UFMylation components—including *UFSP1*—are associated with embryonic lethality in mice and a range of human diseases, including neurological and skeletal disorders, and cancer[1][3]. UFSP1 is not currently known to be directly targeted by approved drugs, nor is it a routine clinical biomarker. No common drugs or clinically used UFSP1-targeting inhibitors or activators are reported, nor are notable safety or toxicity issues specifically described for UFSP1 modulation as of the cited research[1][3].

Other names
Ufm1-specific protease 1UFSP1UfSP1UFSPufm1-specific protease 1UFM1 specific peptidase 1 (inactive)inactive Ufm1-specific protease 1
02

Mechanism of action

Cleavage of the C-terminal Ser-Cys dipeptide from the UFM1 precursor to generate mature UFM1[1][3], Removal of UFM1 from conjugated protein substrates (de-UFMylation)[1][3]

03

Biological functions

Post-translational modification (UFMylation and de-UFMylation)Protein quality controlPro-UFM1 maturationRegulation of UFM1 conjugation/deconjugationCellular homeostasis
04

Disease associations

Neurological disordersSkeletal abnormalitiesCancerOther (mutations in UFMylation pathway genes are implicated in human disease)

Beyond the preview

Go deeper on UFM1 specific peptidase 1 (UFSP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UFM1 specific peptidase 1 (UFSP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call